Bladder Cancer
Prostate Cancer
EAU Edu Platform on Kidney Cancer
Home
Articles
Article of the Month
Editorials
Videos
Webcasts
Education
E-courses
Webinars
Online curriculum
Guidelines
Events
Home
Articles
Terug
Article of the Month
Editorials
Videos
Webcasts
Education
Terug
E-courses
Webinars
Online curriculum
Guidelines
Events
Upcoming event
40th Annual EAU Congress
Home
/
Webcasts
Back
ERUS2024
UROonco2024
EAU 2023
EMUC 22
EAU 2022
EAU21
ESOU21
EMUC20
EAU 20
ESOU20
EMUC 19
RCC 19
ESOU19
EMUC18
Filter
Tags
Article of the Month
,
ASCO GU22
,
ASCO21
,
AUA21
,
Cabozantinib
,
Carcinoma
,
Chronic kidney disease
,
Cryosurgery
,
EAU
,
EAU21
,
EAU22
,
EMUC21
,
EMUC22
,
ERUS22
,
ESMO21
,
Frail patient
,
Glomerular filtration rate
,
Guidelines
,
IMDC risk model
,
Kidney cancer
,
Laparoscopy
,
Lymph node metastases
,
Lymph nodes
,
Metastasectomy
,
Mortality
,
Neoplasm metastasis
,
Neoplasm recurrence
,
Nephrectomy
,
Nephron-sparing surgery
,
Nivolumab
,
Overall survival
,
Partial nephrectomy
,
Prognostication
,
Radical nephrectomy
,
Radical surgery
,
RCC
,
Renal cancer
,
Renal cell
,
Renal cell carcinoma
,
Renal Cell Carcinoma guidelines
,
Renal cryoablation
,
Renal function
,
Renal Transplantation
,
Renorrhaphy
,
Robotic
,
Robotic prostatectomy
,
Robotic surgery
,
Survival outcome
,
Suture
,
Targeted therapies
,
Treatment response
,
Urological surgery
,
UROonco24
,
UROwebinar
,
Webinar
Show all
Rationale for renal cell carcinoma screening
Watch now
Quality of life with open vs robotic-assisted partial nephrectomy (OpeRa) in patients with intermediate/high-complexity renal tumours – Discussant
Watch now
Quality of life with open vs robotic-assisted partial nephrectomy (OpeRa) in patients with intermediate/high-complexity renal tumours
Watch now
89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma – results from phase 3 ZIRCON study
Watch now
89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma – results from phase 3 ZIRCON study – Discussant
Watch now
ESU course 2: Partial nephrectomy I
Watch now
Recent advances in the first-line management of advanced RCC
Watch now
New trial results- Adjuvant therapies in high-risk RCC
Watch now
Multidisciplinary case discussion: First-line treatment in mRCC
Watch now
New trial results – Opera
Watch now
(Neo)adjuvant immunotherapy in renal cancer
Watch now
RAPN for endophytic tumor with rainbow technology
Watch now
Previous
Next